Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer (2019)
- Authors:
- USP affiliated authors: NAGAI, MARIA APARECIDA - FM ; TERRA, RICARDO MINGARINI - FM ; CAPELOZZI, VERA LUIZA - FM ; FABRO, ALEXANDRE TODOROVIC - FMRP
- Unidades: FM; FMRP
- DOI: 10.1016/j.humpath.2018.08.026
- Subjects: NEOPLASIAS CEREBRAIS; METÁSTASE NEOPLÁSICA; NEOPLASIAS PULMONARES; IMUNOHISTOQUÍMICA; SEQUENCIAMENTO GENÉTICO; ONCOGENES; GENES SUPRESSORES
- Agências de fomento:
- Foundation for the Support of Research of the State of Sao Paulo [FAPESP 2013/14277-4]
- Technology and Innovation of Brazil [P246042/2012-5]
- National Counsel of Technological and Scientific Development of the Ministry of Science-CNPq
- MD Anderson's Cancer Center Support Grant from National Cancer Institute [2P3OCA016672]
- University of Texas Lung Specialized Programs of Research Excellence grant [P50CA70907]
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2019
- Source:
- Título: Human pathology
- ISSN: 0046-8177
- Volume/Número/Paginação/Ano: v. 83, p. 177-191, 2019
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
MACHADO-RUGOLO, Juliana et al. Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer. Human pathology, v. 83, p. 177-191, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.humpath.2018.08.026. Acesso em: 27 dez. 2025. -
APA
Machado-rugolo, J., Fabro, A. T., Ascheri, D., Farhat, C., Ab'saber, A. M., Sa, V. K. de, et al. (2019). Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer. Human pathology, 83, 177-191. doi:10.1016/j.humpath.2018.08.026 -
NLM
Machado-rugolo J, Fabro AT, Ascheri D, Farhat C, Ab'saber AM, Sa VK de, Nagai MA, Takagaki T, Terra R, Parra ER, Capelozzi VL. Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer [Internet]. Human pathology. 2019 ; 83 177-191.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.humpath.2018.08.026 -
Vancouver
Machado-rugolo J, Fabro AT, Ascheri D, Farhat C, Ab'saber AM, Sa VK de, Nagai MA, Takagaki T, Terra R, Parra ER, Capelozzi VL. Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer [Internet]. Human pathology. 2019 ; 83 177-191.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.humpath.2018.08.026 - Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients
- Cyclic ACTH-secreting thymic carcinoid: a case report and review of the literature
- PI4K2A. [Editorial]: a novel potential therapeutic target for lung cancer
- Mutation profile and protein expression for predictive testing in lung adenocarcinoma: a study of 200 patients from Brazil
- Variants in epithelial-mesenchymal transition and immune checkpoint genes are associated with immune cell profiles and predict survival in non–small cell lung cancer
- Next-generation sequencing of non-small cell lung cancer using a customized, targeted sequencing panel: focus on epithelial-mesenchymal transition
- Interobserver agreement of usual interstitial pneumonia diagnosis correlated with patient outcome
- Relevance of PD-L1 non-coding polymorphisms on the prognosis of a genetically admixed NSCLC cohort
- Adipose-derived mesenchymal stem cells and their conditioned medium modulate parenchyma remodeling through collagen V and Il-17 pathway in experimental pulmonary fibrosis
- Detection of sputum cofilin-1 as indicator of malignancy
Informações sobre o DOI: 10.1016/j.humpath.2018.08.026 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
002939546.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
